Priebe Waldemar 13D and 13G filings for CNS Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-08-01 5:07 pm Purchase | 2019-12-31 | 13G | CNS Pharmaceuticals, Inc. CNSP | Priebe Waldemar | 3 0.300% | 3 (New Position) | Filing |